37 CFR 1.173 - Reissue specification, drawings, and amendments

Cite as37 CFR 1.173
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX
24 practice notes
  • Patent cases: Patent business goals; implementation,
    • United States
    • Federal Register October 05, 1998
    • 5 octobre 1998
    ...Creating a rocket docket for design applications (37 CFR 1.155); (16) Requiring identification of broadening in a reissue application (37 CFR 1.173); (17) Changing multiple reissue application treatment (37 CFR (18) Creating alternative review procedures for applications under appeal (37 CF......
  • Rules of Practice Before the Board of Patent Appeals and Interferences in Ex Parte
    • United States
    • Federal Register November 22, 2011
    • 22 novembre 2011
    ...in Bd.R. 41.37(c)(1)(iv) for a statement of the status of amendments. Compare 37 CFR 1.121 (requiring all claims ever presented), with 37 CFR 1.173 (reissues) and 37 CFR 1.530 (ex parte reexaminations) (requiring only claims being changed/added). As discussed in further detail below, the US......
  • Hewlett-Packard Co. v. Bausch & Lomb, Inc., No. C-84-20642 RPA.
    • United States
    • United States District Courts. 9th Circuit. United States District Courts. 9th Circuit. Northern District of California
    • 22 juillet 1988
    ...the entire specification and claims of the original patent, with proposed deletions bracketed and proposed additions underlined, 37 CFR § 1.173. A patent examiner reexamines all claims included in the reissue application as if they were presented in an original application, 37 CFR § 1.176. ......
  • Use of Reissue Proceedings in Hatch-Waxman Litigation
    • United States
    • ABA General Library ANDA litigation: strategies and tactics for pharmaceutical patent litigators
    • 2 juin 2016
    ...Comm’r Pat., 195 U.S.P.Q. 136, 137 (D.D.C. 1976). 7. Ex parte Scudder, 169 U.S.P.Q. 814 (Bd. App. 1971). 8. 35 U.S.C. § 251; see also 37 C.F.R. § 1.173. 9. Medrad, Inc. v. Tyco Healthcare Grp. LP, 466 F.3d 1047, 80 U.S.P.Q.2d 1526 (Fed. Cir. 2006); Wilder, 736 F.2d 1516. 10. 37 C.F.R. § 1.6......
  • Request a trial to view additional results
20 cases
  • Hewlett-Packard Co. v. Bausch & Lomb, Inc., No. C-84-20642 RPA.
    • United States
    • United States District Courts. 9th Circuit. United States District Courts. 9th Circuit. Northern District of California
    • 22 juillet 1988
    ...the entire specification and claims of the original patent, with proposed deletions bracketed and proposed additions underlined, 37 CFR § 1.173. A patent examiner reexamines all claims included in the reissue application as if they were presented in an original application, 37 CFR § 1.176. ......
  • Bally Mfg. Corp. v. Diamond, No. 79-1840
    • United States
    • United States Courts of Appeals. United States Court of Appeals (4th Circuit)
    • 2 septembre 1980
    ...the entire specification and claims of the original patent, with proposed deletions bracketed and proposed additions underlined, 37 C.F.R. § 1.173. A patent examiner reexamines all claims included in the reissue application as if they were presented in an original application, 37 C.F.R. § 1......
  • Ex parte King, Appeal 2021-002695
    • United States
    • United States Patent and Trademark Office. United States Patent and Trademark Office, Patent Trial and Appeal Board
    • 1 septembre 2021
    ...and procedurally improper. A Reissue Application must contain the entire specification, including the claims of an Issued Patent. 37 C.F.R. § 1.173(a). The Reissue Application must include the entire text of each claim being changed and each claim being added. 37 C.F.R. § 1.173(b)(2). "Pate......
  • Disney Enters., Inc. v. Rea, No. 1:12cv687 (LMB/TRJ).
    • United States
    • United States District Courts. 4th Circuit. United States District Court (Eastern District of Virginia)
    • 11 avril 2013
    ...... it cannot be extended through the filing of a reissue.”). Although a reissue application may not include any “new matter,” 37 C.F.R. § 1.173; accord35 U.S.C. § 251(a), it is examined in the same manner as a newly submitted application and is generally subject to the same requirements. S......
  • Request a trial to view additional results
1 books & journal articles
  • Use of Reissue Proceedings in Hatch-Waxman Litigation
    • United States
    • ANDA litigation: strategies and tactics for pharmaceutical patent litigators
    • 2 juin 2016
    ...Comm’r Pat., 195 U.S.P.Q. 136, 137 (D.D.C. 1976). 7. Ex parte Scudder, 169 U.S.P.Q. 814 (Bd. App. 1971). 8. 35 U.S.C. § 251; see also 37 C.F.R. § 1.173. 9. Medrad, Inc. v. Tyco Healthcare Grp. LP, 466 F.3d 1047, 80 U.S.P.Q.2d 1526 (Fed. Cir. 2006); Wilder, 736 F.2d 1516. 10. 37 C.F.R. § 1.6......
1 forms
  • Reissue Patent Application Transmittal-AIA/50
    • United States
    • United States Patent and Trademark Office, Patent Trial and Appeal Board
    • Invalid date
    ...Priority Mail Express® Label No. APPLICATION FOR REISSUE OF: Utility Patent (Check applicable box) Design Patent APPLICATION ELEMENTS (37 CFR 1.173) 11. Statement of status and support for all changes to the claims. See 37 CFR 1.173(c). Applicant certifies micro entity status. See 37 CFR 1.......

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT